SEC 13F Intelligence

Ghost Tree Capital, LLC / RETAEUR

Ghost Tree Capital, LLC’s Reata Pharmaceuticals Inc Position

Does Ghost Tree Capital, LLC own Reata Pharmaceuticals Inc (RETAEUR)? Not currently — the last reported position was 85.0K shares worth $9M in Q2 2023; the fund’s latest 13F (Q3 2024) no longer reports it.

Position Value
$9M
Q2 2023
Shares
85.0K
% of Portfolio
+2.86%
Quarters Held
10
position exited

Position History RETAEUR

Reported value by quarter
Q3 ’19: $4MQ3 ’19Q4 ’19: $15MQ1 ’20: $7MQ1 ’20Q2 ’20: $8MQ3 ’20: $3MQ3 ’20Q4 ’21: $1MQ3 ’22: $18MQ3 ’22Q4 ’22: $19MQ1 ’23: $6MQ1 ’23Q2 ’23: $9Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q2 202385.0K$9M+2.86%
Q1 202370.0K$6M+1.88%
Q4 2022500.0K$19M+8.11%
Q3 2022725.0K$18M+5.11%
Q4 202155.0K$1M+0.52%
Q3 202030.0K$3M+0.84%
Q2 202050.0K$8M+2.06%
Q1 202050.0K$7M+1.91%
Q4 201975.0K$15M+2.90%
Q3 201950.0K$4M+1.02%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ghost Tree Capital, LLC’s full portfolio or all institutional holders of RETAEUR.